Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FK.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.1.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.123.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.9.2.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EW.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBPEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.26.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.10.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBTEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CL.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBMEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BR.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CL.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BR.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used